ArticleFrontiers in immunology2025
Risk factors for central hypoventilation in anti-
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anti-NMDA Receptor Encephalitis Associated with Ovarian Teratoma: A Comprehensive Review.Biomedicines · 2026Review
- Early prediction of severe autoimmune encephalitis: development and validation of a model incorporating readily available lactate dehydrogenase.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to identify the risk factors for central hypoventilation in patients with anti- Methods: Patients with anti-NMDAR encephalitis who were hospitalized between January 2020 and January 2025 were identified from the Tianjin Huanhu Hospital database, affiliated with Tianjin University. Patients were categorized into a central hypoventilation group and a non-central hypoventilation group, and potential risk factors were collected. Statistical methods were used to compare the two groups and identify risk factors. Results: The analysis revealed that the central hypoventilation group exhibited a higher incidence of involuntary movements ( Conclusion: Disturbances in consciousness and elevated CSF antibody titers are risk factors for central hypoventilation in patients with anti-NMDAR encephalitis. It is imperative to closely monitor the respiratory status and oxygenation levels of patients identified as high-risk, conduct regular blood gas analyses, and implement respiratory support and more aggressive immunotherapy when necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.